Menu Search
Equities

Charlotte's Web Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6CW:FRA

Charlotte's Web Holdings Inc

Actions
  • Price (EUR)0.452
  • Today's Change0.032 / 7.62%
  • Shares traded12.88k
  • 1 Year change+428.65%
  • Beta2.1508
Data delayed at least 15 minutes, as of Feb 10 2026 07:09 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Charlotte's Web Holdings, Inc. provides hemp extract and other botanical-based wellness products under a family of brands, including Charlotte’s Web, CBD Medic, and CBD Clinic. Charlotte's Web branded full-spectrum CBD products start with proprietary hemp genetics that are 100% North American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids, including cannabidiol (CBD), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids and other beneficial hemp compounds. Charlotte’s Web product categories include functional mushroom gummies, and hemp extract oil tinctures (liquid products), gummies, capsules, topical creams and lotions, and pet products. It also produces NSF Certified for Sport broad-spectrum tincture and gummy products. Charlotte’s Web products are distributed to retail outlets and health care practitioners, and online through its Website at www.charlottesweb.com and other third-party e-commerce sites.

  • Revenue in CAD (TTM)66.74m
  • Net income in CAD-29.39m
  • Incorporated2018
  • Employees112.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.